Clinical trials
Phase 2/3 trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 9 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Recruiting | 17 |
| Terminated | 14 |
| Active, not recruiting | 13 |
| Unknown status | 7 |
| Enrolling by invitation | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 5 |
| Janssen Research & Development, LLC | 5 |
| Boehringer Ingelheim | 4 |
| Sanofi | 4 |
| Universidade do Porto | 4 |
| Hoffmann-La Roche | 3 |
| Pfizer | 3 |
| Biohaven Therapeutics Ltd. | 2 |
| Bristol-Myers Squibb | 2 |
| EyeBiotech Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 5 |
| Alzheimer Disease | 3 |
| Amyloid Neuropathies, Familial | 3 |
| Amyloidosis | 3 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Coronary Artery Disease | 3 |
| HIV Infections | 3 |
| Head and Neck Neoplasms | 3 |
| Hemorrhoids | 3 |
Trials
Showing 51 to 75 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.